CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in MNKD — Mannkind Corp
CIK 884546
SAN FRANCISCO, CA
Position in MNKD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,070,577
+$4,825,363 QoQ
Shares Held
2,598,727
+1.9% QoQ
Ownership
0.808%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. MNKD ranks #102 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in MNKD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,070,577 | 2,598,727 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,245,214 | 2,549,067 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,540,862 | 2,564,526 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,845,589 | 2,578,322 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $9,845,845 | 2,632,579 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $11,222,971 | 2,231,207 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $14,596,781 | 2,270,106 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $13,994,174 | 2,224,829 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $11,394,153 | 2,182,788 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,611,065 | 2,121,648 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $7,523,312 | 2,066,844 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $8,410,377 | 2,036,411 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,955,502 | 1,954,669 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $7,914,566 | 1,930,382 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $10,153,587 | 1,926,677 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,717,451 | 1,850,308 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,843,941 | 1,796,310 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,727,904 | 1,828,235 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $7,738,291 | 1,770,776 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,554,906 | 1,736,760 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $9,316,131 | 1,709,382 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,412,594 | 1,635,866 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,691,028 | 1,498,731 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,761,872 | 1,469,081 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,339,524 | 1,336,871 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $1,228,284 | 1,192,509 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||